Blood Biomarkers in Idiopathic Pulmonary Fibrosis

PURPOSE: Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease of unknown origin whose incidence has been increasing over the latest decade partly as a consequence of population ageing. New anti-fibrotic therapy including pirfenidone and nintedanib have now proven efficacy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Guiot, Julien, Moermans, Catherine, Henket, Monique, Corhay, Jean-Louis, Louis, Renaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
State of the Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437192/
https://www.ncbi.nlm.nih.gov/pubmed/28353114
http://dx.doi.org/10.1007/s00408-017-9993-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437192/
https://www.ncbi.nlm.nih.gov/pubmed/28353114
http://dx.doi.org/10.1007/s00408-017-9993-5

Ejemplares similares